43 related articles for article (PubMed ID: 12535662)
1. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide.
Bauer PM; Buga GM; Ignarro LJ
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12802-7. PubMed ID: 11592976
[TBL] [Abstract][Full Text] [Related]
2. The agonist of the protease-activated receptor-1 (PAR) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human smooth muscle cells.
Arisato T; Sarker KP; Kawahara K; Nakata M; Hashiguchi T; Osame M; Kitajima I; Maruyama I
Cell Mol Life Sci; 2003 Aug; 60(8):1716-24. PubMed ID: 14513837
[TBL] [Abstract][Full Text] [Related]
3. Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.
Eschrich J; Meyer R; Kuk H; Wagner AH; Noppeney T; Debus S; Hecker M; Korff T
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908399
[TBL] [Abstract][Full Text] [Related]
4. Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses.
Schiefelbein D; Goren I; Fisslthaler B; Schmidt H; Geisslinger G; Pfeilschifter J; Frank S
J Biol Chem; 2008 May; 283(22):15479-90. PubMed ID: 18390541
[TBL] [Abstract][Full Text] [Related]
5. The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
Moreau AS; Jia X; Patterson CJ; Roccaro AM; Xu L; Sacco A; O'Connor K; Soumerai J; Ngo HT; Hatjiharissi E; Hunter ZR; Ciccarelli B; Manning R; Ghobrial IM; Leleu X; Treon SP
Br J Haematol; 2008 Sep; 142(5):775-85. PubMed ID: 18537966
[TBL] [Abstract][Full Text] [Related]
6. Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression.
Poulaki V; Mitsiades N; Kruse FE; Radetzky S; Iliaki E; Kirchhof B; Joussen AM
Am J Pathol; 2004 Apr; 164(4):1293-302. PubMed ID: 15039217
[TBL] [Abstract][Full Text] [Related]
7. ERRATUM: Simvastatin profoundly impairs energy metabolism in primary human muscle cells.
Mäkinen S; Datta N; Nguyen YH; Kyrylenko P; Laakso M; Koistinen HA
Endocr Connect; 2022 Jul; 11(7):. PubMed ID: 37931405
[No Abstract] [Full Text] [Related]
8. A biomimetic orthogonal-bilayer tubular scaffold for the co-culture of endothelial cells and smooth muscle cells.
Li MX; Li L; Zhou SY; Cao JH; Liang WH; Tian Y; Shi XT; Yang XB; Wu DY
RSC Adv; 2021 Sep; 11(50):31783-31790. PubMed ID: 35496878
[TBL] [Abstract][Full Text] [Related]
9. Modified electrospun chitosan membranes for controlled release of simvastatin.
Murali VP; Fujiwara T; Gallop C; Wang Y; Wilson JA; Atwill MT; Kurakula M; Bumgardner JD
Int J Pharm; 2020 Jun; 584():119438. PubMed ID: 32433935
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of chitosan scaffolds combined with simvastatin-loaded nanoparticles for guided bone regeneration.
Xue Y; Wu M; Liu Z; Song J; Luo S; Li H; Li Y; Jin L; Guan B; Lin M; Chen F; Jin C; Liu D; Li Y; Zhang X
J Mater Sci Mater Med; 2019 Apr; 30(4):47. PubMed ID: 30980130
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Simvastatin on Ischemia Reperfusion Injury in an Experimental Colon Anastomosis Model.
Akarsu M; Saygun O; Aydinuraz K; Aydin O; Daphan CE; Tanrıkulu FB; Kisa U; Comu FM
Indian J Surg; 2017 Oct; 79(5):390-395. PubMed ID: 29089696
[TBL] [Abstract][Full Text] [Related]
12. Effect of in-situ application of simvastatin gel in surgical management of osseous defects in chronic periodontitis-A randomized clinical trial.
Ranjan R; Patil SR; H R V
J Oral Biol Craniofac Res; 2017; 7(2):113-118. PubMed ID: 28706785
[TBL] [Abstract][Full Text] [Related]
13. Multiple drilling combined with simvastatin versus multiple drilling alone for the treatment of avascular osteonecrosis of the femoral head: 3-year follow-up study.
Yin H; Yuan Z; Wang D
BMC Musculoskelet Disord; 2016 Aug; 17(1):344. PubMed ID: 27528281
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast/myofibroblast apoptosis in the regeneration/healing process from TNBS-induced colitis.
Abe Y; Murano M; Murano N; Morita E; Inoue T; Kawakami K; Ishida K; Kuramoto T; Kakimoto K; Okada T; Narabayashi K; Umegaki E; Higuchi K
Dig Dis Sci; 2012 Feb; 57(2):335-44. PubMed ID: 21909991
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes.
Lee SG; Kim JL; Lee HK; Ryu GW; Hur DY; Yun IH; Yang JW; Kim HW
Graefes Arch Clin Exp Ophthalmol; 2011 Mar; 249(3):389-97. PubMed ID: 20821229
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin improves wound strength after intestinal anastomosis in the rat.
Karadeniz Cakmak G; Irkorucu O; Ucan BH; Emre AU; Bahadir B; Demirtas C; Tascilar O; Karakaya K; Acikgoz S; Kertis G; Ankarali H; Pasaoglu H; Comert M
J Gastrointest Surg; 2009 Sep; 13(9):1707-16. PubMed ID: 19578821
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
Osorio JC; Cheema FH; Martens TP; Mahmut N; Kinnear C; Gonzalez AM; Bonney W; Homma S; Liao JK; Mital S
Can J Physiol Pharmacol; 2008 Sep; 86(9):633-42. PubMed ID: 18758513
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy.
Dulak J; Józkowicz A
Curr Cancer Drug Targets; 2005 Dec; 5(8):579-94. PubMed ID: 16375664
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin stimulates VEGF release via p44/p42 MAP kinase in vascular smooth muscle cells.
Takenaka M; Hirade K; Tanabe K; Akamatsu S; Dohi S; Matsuno H; Kozawa O
Biochem Biophys Res Commun; 2003 Jan; 301(1):198-203. PubMed ID: 12535662
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
